Bile acids: emerging role in management of liver diseases

Hepatology International

Volumn 9, Issue 4, 2015, Pages 527-533

  Asgharpour, Amon ^a   Kumar, Divya ^a   Sanyal, Arun ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Bile acids; FXR; Liver disease; TGR5

Indexed keywords

BILE ACID; CHOLESTEROL; G PROTEIN COUPLED RECEPTOR; GLUCOSE; LIPID; OBETICHOLIC ACID; CHENODEOXYCHOLIC ACID; GASTROINTESTINAL AGENT; GPBAR1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROSCLEROSIS; BILE ACID SYNTHESIS; CELL MEMBRANE; CONTROLLED STUDY; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; INFLAMMATION; LIPID METABOLISM; LIVER DISEASE; LIVER FIBROSIS; METABOLIC SYNDROME X; MOUSE; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; REVIEW; VASCULAR RESISTANCE; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; LIVER DISEASES; METABOLISM; PHYSIOLOGY;

ANIMALS; BILE ACIDS AND SALTS; CHENODEOXYCHOLIC ACID; GASTROINTESTINAL AGENTS; HUMANS; LIVER DISEASES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84944516583     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-015-9656-7     Document Type: Review

References (54)

1. Dawson PA, Shneider BL, Hofmann AF. Bile formation and the enterohepatic circulation. In: Physiology of the gastrointestinal tract, 4th edn. San Diego: Elsevier; 2006. 1437–1462
2. Agellon LB. Metabolism and function of bile acids. In: Biochemistry of lipids, lipoproteins and membranes, 5th edn. Amsterdam: Elsevier; 2008. 423–440
3. Schiff ER, Dietschy JM. Current concepts of bile acid absorption. Am J Clin Nutr 1969;22:273–278
4. Houten SM, Watanabe M, Auwerx J. Endocrine functions of bile acids. EMBO J 2006;25:1419–1425
5. Hofmann AF. The enterohepatic circulation of bile acids in mammals: form and functions. Front Biosci 2009;14:2584–2598
6. Keitel V, Kubitz R, Haussinger D. Endocrine and paracrine role of bile acids. World J Gastroenterol 2008;14:5620–5629
7. Hylemon PB, Zhou H, Pandak WM, Ren S, Gil G, Dent P. Bile acids as regulatory molecules. J Lipid Res 2009;50:1509–1520
8. Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 2003;72:137–174
9. Li T, Chiang JY. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev 2014;66:948–983
10. Hofmann AF. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 1999;159:2647–2658
11. Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006;47:241–259
12. Dietschy JM. Mechanisms for the intestinal absorption of bile acids. J Lipid Res 1968;9:297–309
13. 2+ ions. J Lipid Res 1992;33:617–626
14. Chiang JY. Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev 2002;23:443–463
15. Li T, Chiang JY. Bile Acid signaling in liver metabolism and diseases. J Lipids 2012;2012:754067
16. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009;89:147–191
17. Chiang JY. Bile acids: regulation of synthesis. J Lipid Res 2009;50:1955–1966
18. Hofmann AF. Biliary secretion and excretion in health and disease: current concepts. Ann Hepatol 2007;6:15–27
19. Weinman SA, Jalil S. Bile secretion and cholestasis. In Textbook of gastroenterology. Oxford: Blackwell; 2008. 401–421
20. Dawson PA, Lan T, Rao A. Bile acid transporters. J Lipid Res 2009;50:2340–2357
21. St-pierre MV, Kullak-ublick GA, Hagenbuch B, Meier PJ. Transport of bile acids in hepatic and non-hepatic tissues. J Exp Biol 2001;204:1673–1686
22. Alrefai WA, Gill RK. Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res 2007;24:1803–1823
23. Wang DQH, Neuschwander-Tetri BA, Portincasa P. The biliary system. In Colloquium series on integrated systems physiology: from molecule to function. Morgan & Claypool; 2012. 109–145
24. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, et al. Identification of a nuclear receptor for bile acids. Science 1999;284:1362–1365
25. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science 1999;21:1365–1368
26. Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 1999;3:543–553
27. Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, Mackenzie KI, LaTour A, et al. The nuclear receptor PXR is a lithocholic acid sensor that protect against liver toxicity. Proc Natl Acad Sci USA 2000;98:3369–3374
28. Xie W, Radominska-Pandya A, Shi Y, Simon CM, Nelson MC, Ong ES, et al. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA 2001;98:3370–3380
29. Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, et al. Vitamin D receptor as an intestinal bile acid sensor. Science 2002;296:1313–1316
30. Matsubara T, Li F, Gonzalez FJ. FXR signaling in the enterohepatic system. Mol Cell Endocrinol 2013;368:17–29
31. Lee FY, Lee H, Hubbert ML, Edwards PA, Zhang Y. FXR, a multipurpose nuclear receptor. Trends Biochem Sci 2006;31:572–580
32. Claudel T, Staels B, Kuipers F. The farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler Thromb Vasc Biol 2005;25:2020–2030
33. Teodoro JS, Rolo AP, Palmeira CM. Hepatic FXR: key regulator of whole-body energy metabolism. Trends Endocrinol Metab 2011;22:458–466
34. Fiorucci S, Cipriani S, Baldelli F, Mencarelli A. Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. Prog Lipid Res 2010;49:171–185
35. Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M, et al. A G protein-coupled receptor responsive to bile acids. J Biol Chem 2003;278:9435–9440
36. Maruyama T, Miyamoto Y, Nakamura T, Tamai Y, Okada H, Sugiyama E, et al. Identification of membrane-type receptor for bile acids (M-BAR). Biochem Biophys Res Commun 2002;298:714–719
37. Tiwari A, Maiti P. TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders. Drug Discov Today 2009;14:523–530
38. Duboc H, Taché Y, Hofmann AF. The bile acid TGR5 membrane receptor: from basic research to clinical application. Dig Liver Dis 2014;46:302–312
39. Lieu T, Jayaweera G, Bunnett NW. GPBA: a GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation. Br J Pharmacol 2014;171:1156–1166
40. Bunnett NW. Neuro-humoral signaling by bile acids and the TGR5 receptor in the gastrointestinal tract. J Physiol 2014;592:2943–2950
41. Ferrari C, Macchiarulo A, Costantino G, Pellicciari R. Pharmacophore model for bile acids recognition by the FPR receptor. J Comput Aided Mol Des 2006;20:295–303
42. Zhou H, Hylemon PB. Bile acids are nutrient signaling hormones. Steroids 2014;86:62–68
43. Ma K, Saha PK, Chan L, Moore DD. Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest 2006;116:1102–1119
44. Hambruch et al. J Pharmacol Exp Ther 2012;343(3):556–567
45. Miyazaki-Anzai S, Masuda M, Levi M, Keenan AL, Miyazaki M. Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis. PLoS One 2014;9(9):e108270
46. Neuschwander-Tetri BA, Loomba R, Sanyal AJ, et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet 2014;S0140–6736(14):61933–61934
47. Verbeke L, Farre R, Trebicka J, et al. Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats. Hepatology 2014;59:2286–2298
48. Fiorucci S, Antonelli E, Rizzo G, Renga B, Mencarelli A, Riccardi L, et al. The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. Gastroenterology 2004;127(5):1497–1512
49. NIDDKwebsite:http://www.niddk.nih.gov/news/for-reporters/Pages/interim-results-FLINT-clinical-trial.aspx
50. Katsuma S, Hirasawa A, Tsujimoto G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 2005;329:386–390
51. Thomas C, Gioliello A, Noriega L, Strehle A, Oury J, Rizzo G, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009;10:167–177
52. Doyle ME, Egan JM. Mechanisms of action of GLP-1 in the pancreas. Pharmacol Ther 2008;113:546–593
53. Thomas C, Auwerx J, Schoonjans K. Bile acids and the membrane bile acid receptor TGR5-connecting nutrition and metabolism. Thyroid 2008;18:167–174
54. Chen X, Lou G, Meng Z, Huang W. TGR5: a novel target for weight maintenance and glucose metabolism. Exp Diabetes Res 2011;853501–803506:2011